Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin (Q80347621)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Z Y Lim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

S Killick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

U Germing

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

J Cavenagh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

D Culligan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A Bacigalupo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

J Marsh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

G J Mufti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

17 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1436-1441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507999%20AND%20SRC:MED&resulttype=core&format=json

Myelodysplastic syndromes: a scoring system with prognostic significance

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Antithymocyte globulin for patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Comparative analysis of the in vitro proliferation and expansion of hematopoietic progenitors from patients with aplastic anemia and myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

The pathophysiology of acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021

Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404747

7 January 2021